| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 452 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 449 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet Neurology, 2024 | 439 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … The Lancet, 2024 | 296 | 2024 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 197 | 2024 |
| The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases R Mirzaei, F Zamani, M Hajibaba, A Rasouli-Saravani, M Noroozbeygi, ... Journal of neuroimmunology 358, 577640, 2021 | 93 | 2021 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 82 | 2024 |
| Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases A Rasouli-Saravani, K Jahankhani, S Moradi, M Gorgani, Z Shafaghat, ... Biomedicine & Pharmacotherapy 162, 114620, 2023 | 49 | 2023 |
| HLA-DRB1* 04 may predict the severity of disease in a group of Iranian COVID-19 patients S Ebrahimi, HR Ghasemi-Basir, MM Majzoobi, A Rasouli-Saravani, ... Human Immunology 82 (10), 719-725, 2021 | 23 | 2021 |
| Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease … D Bryazka, MB Reitsma, YH Abate, AHA Abd Al Magied, A Abdelkader, ... The lancet Public health 9 (10), e729-e744, 2024 | 18 | 2024 |
| Immunometabolism in human brucellosis: An emerging field of investigation R Mirzaei, M Sholeh, S Jalalifar, E Zafari, S Kazemi, A Rasouli-Saravani, ... Microbial Pathogenesis 158, 105115, 2021 | 17 | 2021 |
| Investigation of Linc-MAF-4 expression as an effective marker in brucellosis R Gheitasi, F Keramat, G Solgi, M Hajilooi Molecular Immunology 123, 60-63, 2020 | 10 | 2020 |
| Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050 Y Jin, C Guo, M Abbasian, M Abbasifard, JH Abbott, A Abdullahi, A Abedi, ... Med 5 (8), 943-962. e6, 2024 | 8 | 2024 |
| Relevance of autoantibody profile with HLA-DRB1 and-DQB1 alleles in a group of Iranian systemic lupus erythematosus patients A Rasouli-Saravani, A Tahamoli-Roudsari, Z Basiri, M Babaei, A Fazaeli, ... Immunology Letters 237, 11-16, 2021 | 7 | 2021 |
| Clinical relevance of HLA-DRB1 and-DQB1 alleles in iranian systemic lupus erythematosus patients A Rasouli-Saravani, A Tahamoli-Roudsari, M Behzad, M Hajilooi, G Solgi Iranian Journal of Allergy, Asthma and Immunology 20 (1), 67-75, 2021 | 7 | 2021 |
| Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? MT Anvar, K Rashidan, N Arsam, A Rasouli-Saravani, H Yadegari, ... Cancer Cell International 24 (1), 355, 2024 | 6 | 2024 |
| Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis RAS Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Shahram ... International Journal of Rheumatic Diseases 26 (7), 1227-1234, 2023 | 4 | 2023 |
| Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic … HH Kyu, A Vongpradith, RMV Dominguez, J Ma, SB Albertson, ... The Lancet Infectious Diseases, 2024 | 3 | 2024 |
| A systematic review of machine learning-based tumor-infiltrating lymphocytes analysis in colorectal cancer: Overview of techniques, performance metrics, and clinical outcomes A Kazemi, A Rasouli-Saravani, M Gharib, T Albuquerque, S Eslami, ... Computers in Biology and Medicine, 108306, 2024 | 3 | 2024 |
| Peripheral blood expressions of MicroRNA-146a and MicroRNA-218 in chronic obstructive pulmonary disease with/without cigarette smoke exposure E Nadi, G Geramirad, Z Kahramfar, A Rasuli-Saravani, G Solgi Iranian Journal of Allergy, Asthma and Immunology 21 (4), 399-406, 2022 | 2 | 2022 |
Ghasem SolgiProfessor of Immunology, Hamadan University of Medical SciencesE-mailová adresa ověřena na: umsha.ac.ir